-
Careful evaluation of epidemiologic data from recent African outbreaks of meningococcal disease suggests that significant risks now extend beyond the sub-Saharan belt through the Rift Valley and Great Lakes regions into Mozambique, then into Namibia and Angola.
-
Although Japanese encephalitis rarely occurs in travelers, certain groups and subsets of individuals have a risk of infection that can reach 1 in 5000 travelers per week. It is crucial to recognize those with increased risk, and to seriously consider immunizing them in order to prevent the potentially devastating sequelae of Japanese encephalitis.
-
The first stage of smallpox vaccination has begun, even before the doses are released or a final plan formulated. Across the country, hospitals are educating health care workers about smallpox and the vaccinia vaccine.
-
Hospitals will have considerable leeway to make their own decisions about who and how many health care workers will be immunized for smallpox if the government moves ahead as expected and offers the vaccine to medical personnel.
-
The Centers for Disease Control and Preventions Advisory Committee on Immunization Practices cites these contraindications for receipt of smallpox vaccine.
-
Health care workers with HIV or a history of atopic dermatitis are at real risk of serious complications if they receive smallpox vaccine. But can they be safely screened out if as appears imminent 500,000 hospital workers are offered smallpox immunization?
-
Declining rates of response to standard treatment for non-gonococcal urethritis (NGU) may prompt changes in accepted treatment strategies.
-
From 2001 to 2013, Bailey and colleagues studied 65,480 children in a primary care network affiliated with Children’s Hospital of Pennsylvania that covered urban and suburban parts of Pennsylvania, New Jersey, and Delaware.
-
Dalbavancin is a lipoglycopeptide antibiotic for intravenous administration with activity against Gram-positive organisms, including methicillin resistant Staphylococcus aureus that is distinguished by its extraordinarily long serum half-life that allows once weekly dosing.
-
A 52-year-old woman with no significant past medical history presented to Stanford Hospital in July, 2014, with fever and progressive weakness. She had been in her usual state of health until the day prior to admission, when she began to feel fatigued with subjective fevers and “restless legs.”